Hypercholesterolemia Trials in Winter Park, United States
Conditions / Hypercholesterolemia / Winter Park, United States
Research into Hypercholesterolemia spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05952869 | A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH) | COMPLETED | PHASE3 |
| NCT01475825 | A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol | COMPLETED | PHASE3 |
| NCT02608697 | A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia | COMPLETED | PHASE2 |
| NCT01730053 | Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II) | COMPLETED | PHASE3 |
| NCT01912560 | Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia | COMPLETED | PHASE2 |
| NCT00794664 | Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis | COMPLETED | PHASE3 |
| NCT00267280 | A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). | TERMINATED | PHASE3 |
| NCT06492291 | Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00694109 | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia | COMPLETED | PHASE3 |
| NCT03175367 | Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia | COMPLETED | PHASE2 |